The healthcare landscape is witnessing a significant transformation, with technology-driven companies like PharmEasy leading the charge. The anticipated PharmEasy IPO is not just an investment opportunity but a window into the future of digital healthcare in India.
Opening Date
Closing Date
Price Band
Issue Size
Face Value
Market Lot
Listing at NSE, BSE
| IPO Open Date | To be announced |
|---|---|
| IPO Close Date | To be announced |
| Allotment Date | To be announced |
| Initiation Of Refunds | To be announced |
| Credit Of Shares To Demat Account |
To be announced |
| IPO Listing Date | To be announced |
| UPI Mandate Expiry Date | To be announced |
Checkout the List of Upcoming IPO
Founded in 2015 by Dharmil Sheth and Dr. Dhaval Shah, PharmEasy has rapidly emerged as a titan in the healthcare sector. Its parent company, API Holdings Limited, has pioneered a digitally enabled platform offering various services, from online medicine orders and diagnostic tests to doctor consultations. What sets PharmEasy apart is its robust supply chain, advanced technology, and a deep understanding of India's healthcare dynamics, serving over 25 million registered users.
PharmEasy's growth trajectory is reflected in its financial performance. A glance at the recent financial years reveals a company on the rise, ready to leverage the IPO for further growth.
| Financial Year | Total Assets (Rs. Million) | Total Revenue (Rs. Million) | Profit After Tax (Rs. Million) |
|---|---|---|---|
| FY 2021 | 49,053.44 | 29,809 | 6,410 |
| FY 2020 | 5,724.75 | 10,840 | 3,350 |
| Strengths | Weaknesses | ||
|---|---|---|---|
| All-in-one healthcare integrated platform. | Vulnerable to e-commerce laws and regulations changes. | ||
| First-in-line, custom-built healthcare supply chain. | Compliance requirements in healthcare could be restrictive. | ||
| Trusted partner of choice among stakeholders. | Dependency on customer engagement for the digital platform. | ||
| Pursues strategic acquisitions for growth. | Technological infrastructure maintenance is critical. | ||
| Consistent innovation for enhanced customer experience. | Brand reputation management is essential. | ||
| Expanding product and service offerings with stable funding. | Previous losses and negative cash flows raise concerns. | ||
A simple and smartest way to Apply in IPO online via Religare Dynami Mobile App
Retail investors need to apply for the IPO using UPI
Fill up your personal details in the form above
Fill up your DOB, PAN, email & bank account details
Upload your photo and e-sign your application via Aadhaar OTP
The price band of the company’s IPO is yet to be announced. Please stay tuned for updates.
The size of the company is yet to be announced. Further details will be provided once available.
The minimum lot size of the IPO is yet to be announced. Please await further information regarding this IPO.
Copyright 2010 Religare. Trademarks are the property of their respective owners. All rights reserved. Please note that by submitting your mobile and email on our website, you are authorizing us to Call/SMS/Whtsapp/RCS/Email you even though you may be registered under DNC. We shall Call/SMS you for a period of 12 months.
Religare Broking Limited (RBL): Registered Office: 2nd Floor, P-14, 45/90, P-Block, Connaught Place, New Delhi 110001. Board line number: 011-49871213. Fax No.: 011-49871189
Religare Broking Limited: SEBI Regn. No. INZ000174330 NSE CM, F&O, CD TM Code: 06537 Clearing Member (F&O) No. M50235; BSE CM, F&O, CD, CO TM Code: 3004 Clearing No: 3004; MSE CM, F&O, CD, TM Code: 1051 | MCX Membership No. 56560 | NCDEX Membership No. 01276 | AMFI ARN No.139809. Depository Participant: NSDL: DP ID: IN 301774 | CDSL DP ID: 30200 - SEBI Regn. No: IN-DP-385-2018. | Research Analyst Regn.No: INH100006977 | PFRDA POP registration No. 01092018 | IRDA Corporate Agent
Registration No: CA0581 | Company CIN : U65999DL2016PLC314319.
Disclaimer : Investment in securities market are subject to market risks, read all the related documents carefully before investing. RBL is a distributor of Mutual Funds / IPOs / Insurance / Bonds & NCDs. Equities, Currencies & Depository Services are offered through Religare Broking Ltd.
To remain updated on the latest market updates follow us at
